|
What would a successful BETonMACE Top-Line Data Announcement Look Like?
|
7
|
Resverlogix Corp.
|
Aug 10, 2019 12:01PM
|
|
Re: If we follow AMRN's pattern...
|
2
|
Resverlogix Corp.
|
Aug 09, 2019 06:43PM
|
|
Re: Financials
|
4
|
Zenith Epigenetics
|
Aug 09, 2019 12:17PM
|
|
Of relevance to Resverlogix's planned Fabry Disease trial
|
3
|
Resverlogix Corp.
|
Aug 09, 2019 11:34AM
|
|
ZEN-3694 synergy with enzalutamide and PARP inhibitors
|
7
|
Zenith Epigenetics
|
Aug 09, 2019 11:19AM
|
|
Re: Financials
|
6
|
Zenith Epigenetics
|
Aug 09, 2019 11:05AM
|
|
Re: ALP Levels Predict Adverse Cardiovascular Outcomes And Cognitive Impairment In High Risk Patients
|
4
|
Resverlogix Corp.
|
Aug 08, 2019 10:26PM
|
|
Re: If we follow AMRN's pattern...
|
2
|
Resverlogix Corp.
|
Aug 08, 2019 09:46PM
|
|
Re: AMRN Adcom
|
3
|
Resverlogix Corp.
|
Aug 08, 2019 09:40PM
|
|
ALP Levels Predict Adverse Cardiovascular Outcomes And Cognitive Impairment In High Risk Patients
|
5
|
Resverlogix Corp.
|
Aug 08, 2019 12:39PM
|
|
Re: Possible news releases for Resverlogix based on Amarin/ESC/AHA
|
3
|
Resverlogix Corp.
|
Aug 07, 2019 03:57PM
|
|
Re: Possible news releases for Resverlogix based on Amarin/ESC/AHA
|
7
|
Resverlogix Corp.
|
Aug 07, 2019 03:45PM
|
|
Possible news releases for Resverlogix based on Amarin/ESC/AHA
|
9
|
Resverlogix Corp.
|
Aug 07, 2019 01:04PM
|
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
9
|
Zenith Epigenetics
|
Aug 06, 2019 12:39PM
|
|
Zenith Licensing Agreement
|
5
|
Resverlogix Corp.
|
Aug 06, 2019 08:40AM
|
|
Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
4
|
Zenith Epigenetics
|
Aug 06, 2019 08:37AM
|
|
Zacks SCR 8/5/19: Targeting September Readout for BETonMACE
|
4
|
Resverlogix Corp.
|
Aug 05, 2019 11:52AM
|
|
Re: Liquidity
|
3
|
Zenith Epigenetics
|
Aug 02, 2019 03:06PM
|
|
Re: Resverlogix Announces Loan Reduction and Extension
|
8
|
Resverlogix Corp.
|
Aug 02, 2019 02:48PM
|
|
Re: Resverlogix Announces Loan Reduction and Extension
|
9
|
Resverlogix Corp.
|
Aug 02, 2019 12:20PM
|
